
2365. excretion oestrone, pregnanediol 
pregnanetriol breast 
cancer patients.  i. excretion spontaneous 
menopause 
urinary excretion oestrone, pregnanediol 
pregnanetriol determined 
series postmenopausal breast cancer patients 
receiving endocrine treat- 
ment.  steroid excretion studied 
relation age patients 
well relation time elapsed 
since last menstrual cycle.  results 
indicate initial slow decrease 
age menopause onward, 
excretion oestrone preganediol 
increases again.  new maximum 
found group 10-15 yr. 
menopause.  excretion pregnanetriol 
however, remains relatively constant 
rapid fall first 
years menopause. 
